Fevipiprant ( QAW 039 ) , a Slowly Dissociating CRTh 2 Antagonist with the Potential for Improved Clinical Efficacy s
暂无分享,去创建一个
S. Watson | S. Charlton | D. Sykes | D. Riddy | J. Reilly | D. Sandham | M. Bradley | G. Dubois | E. Willard | Asadh Miah | C. Bauer | Darren M. Riddy | Michelle E. Bradley